|
1
|
Hossain MA, Kim DH, Jang JY, Kang YJ, Yoon
JH, Moon JO, Chung HY, Kim GY, Choi YH, Copple BL, et al: Aspirin
induces apoptosis in vitro and inhibits tumor growth of human
hepatocellular carcinoma cells in a nude mouse xenograft model. Int
J Oncol. 40:1298–1304. 2012.
|
|
2
|
Fuster V and Sweeny JM: Aspirin: A
historical and contemporary therapeutic overview. Circulation.
123:768–778. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dovizio M, Bruno A, Tacconelli S and
Patrignani P: Mode of action of aspirin as a chemopreventive agent.
Recent Results Cancer Res. 191:39–65. 2013. View Article : Google Scholar
|
|
4
|
Jankowska H, Hooper P and Jankowski JA:
Aspirin chemoprevention of gastrointestinal cancer in the next
decade. A review of the evidence. Pol Arch Med Wewn. 120:407–412.
2010.PubMed/NCBI
|
|
5
|
Goel A, Chang DK, Ricciardiello L, Gasche
C and Boland CR: A novel mechanism for aspirin-mediated growth
inhibition of human colon cancer cells. Clin Cancer Res. 9:383–390.
2003.PubMed/NCBI
|
|
6
|
Cooper K, Squires H, Carroll C,
Papaioannou D, Booth A, Logan RF, Maguire C, Hind D and Tappenden
P: Chemoprevention of colorectal cancer: Systematic review and
economic evaluation. Health Technol Assess. 14:1–206. 2010.
View Article : Google Scholar
|
|
7
|
Chen C, Hu JT, Tu YJ, Wu JC, Liang J, Gao
LL, Wang ZG, Yang BF and Dong DL: Effects of isosorbide mononitrate
on the restoration of injured artery in mice in vivo. Eur J
Pharmacol. 640:150–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaufman R, Nunes I, Bolognese JA, Miller
DL, Salotti D, McCarthy JM, Smith WB, Herman GA and Feig PU:
Single-dose effects of isosorbide mononitrate alone or in
combination with losartan on central blood pressure. J Am Soc
Hypertens. 4:311–318. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wallace JL and Del Soldato P: The
therapeutic potential of NO-NSAIDs. Fundam Clin Pharmacol.
17:11–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pipili-Synetos E, Papageorgiou A, Sakkoula
E, Sotiropoulou G, Fotsis T, Karakiulakis G and Maragoudakis ME:
Inhibition of angiogenesis, tumour growth and metastasis by the
NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br
J Pharmacol. 116:1829–1834. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Usman MW, Luo F, Cheng H, Zhao JJ and Liu
P: Chemopreventive effects of aspirin at a glance. Biochim Biophys
Acta. 1855:254–263. 2015.PubMed/NCBI
|
|
12
|
Tan Z, Shang X, Li L, Tian L, Ma Y, Peng Y
and Gao L: Clinical study of isosorbide mononitrate treatment for
angina pectoris in coronary heart disease. Exp Ther Med.
5:1133–1136. 2013.PubMed/NCBI
|
|
13
|
Palmer RM, Ferrige AG and Moncada S:
Nitric oxide release accounts for the biological activity of
endothelium-derived relaxing factor. Nature. 327:524–526. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ignarro L: Nitric oxide biology and
pathobiology. 2nd edition. Academic Press; New York: 2009
|
|
15
|
Shah V, Lyford G, Gores G and Farrugia G:
Nitric oxide in gastrointestinal health and disease.
Gastroenterology. 126:903–913. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu W, Liu LZ, Loizidou M, Ahmed M and
Charles IG: The role of nitric oxide in cancer. Cell Res.
12:311–320. 2002. View Article : Google Scholar
|
|
17
|
Mocellin S, Bronte V and Nitti D: Nitric
oxide, a double edged sword in cancer biology: Searching for
therapeutic opportunities. Med Res Rev. 27:317–352. 2007.
View Article : Google Scholar
|
|
18
|
Rigas B and Kashfi K:
Nitric-oxide-donating NSAIDs as agents for cancer prevention.
Trends Mol Med. 10:324–330. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Williams JL, Nath N, Chen J, Hundley TR,
Gao J, Kopelovich L, Kashfi K and Rigas B: Growth inhibition of
human colon cancer cells by nitric oxide (NO)-donating aspirin is
associated with cyclooxygenase-2 induction and beta-catenin/T-cell
factor signaling, nuclear factor-kappaB, and NO synthase 2
inhibition: Implications for chemoprevention. Cancer Res.
63:7613–7618. 2003.PubMed/NCBI
|
|
20
|
Khan NI, Cisterne A, Baraz R, Bradstock KF
and Bendall LJ: Para-NO-aspirin inhibits NF-kappaB and induces
apoptosis in B-cell progenitor acute lymphoblastic leukemia. Exp
Hematol. 40:207–215. e12012. View Article : Google Scholar
|
|
21
|
Yang Y, Yang JJ, Tao H and Jin WS: New
perspectives on beta-catenin control of cell fate and proliferation
in colon cancer. Food Chem Toxicol. 74:14–19. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang Y: Wnt signaling in development and
disease. Cell Biosci. 2:142012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu D, Cottam HB, Corr M and Carson DA:
Repression of beta-catenin function in malignant cells by
nonsteroidal antiin-flammatory drugs. Proc Natl Acad Sci USA.
102:18567–18571. 2005. View Article : Google Scholar
|
|
24
|
Nath N, Liu X, Jacobs L and Kashfi K:
Flurbiprofen benzyl nitrate (NBS-242) inhibits the growth of A-431
human epidermoid carcinoma cells and targets β-catenin. Drug Des
Devel Ther. 7:389–396. 2013.
|
|
25
|
Kang YJ, Park HJ, Chung HJ, Min HY, Park
EJ, Lee MA, Shin Y and Lee SK: Wnt/β-catenin signaling mediates the
antitumor activity of magnolol in colorectal cancer cells. Mol
Pharmacol. 82:168–177. 2012. View Article : Google Scholar : PubMed/NCBI
|
